These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 19656885)

  • 1. Analysis of human cytomegalovirus-encoded microRNA activity during infection.
    Stern-Ginossar N; Saleh N; Goldberg MD; Prichard M; Wolf DG; Mandelboim O
    J Virol; 2009 Oct; 83(20):10684-93. PubMed ID: 19656885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytomegalovirus microRNA miR-US25-1-5p inhibits viral replication by targeting multiple cellular genes during infection.
    Jiang S; Qi Y; He R; Huang Y; Liu Z; Ma Y; Guo X; Shao Y; Sun Z; Ruan Q
    Gene; 2015 Oct; 570(1):108-14. PubMed ID: 26055091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human cytomegalovirus-encoded microRNA regulates expression of multiple viral genes involved in replication.
    Grey F; Meyers H; White EA; Spector DH; Nelson J
    PLoS Pathog; 2007 Nov; 3(11):e163. PubMed ID: 17983268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of human cytomegalovirus miR-US25-1-5p and miR-UL112-3p in serum extracellular vesicles from infants with HCMV active infection are significantly correlated with liver damage.
    Zhang J; Huang Y; Wang Q; Ma Y; Qi Y; Liu Z; Deng J; Ruan Q
    Eur J Clin Microbiol Infect Dis; 2020 Mar; 39(3):471-481. PubMed ID: 31749099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cytomegalovirus latent infection alters the expression of cellular and viral microRNA.
    Fu M; Gao Y; Zhou Q; Zhang Q; Peng Y; Tian K; Wang J; Zheng X
    Gene; 2014 Feb; 536(2):272-8. PubMed ID: 24361963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10).
    Ahn JH; Jang WJ; Hayward GS
    J Virol; 1999 Dec; 73(12):10458-71. PubMed ID: 10559364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Requirement of Human Cytomegalovirus UL112-113 Protein Isoforms for Viral Replication.
    Schommartz T; Tang J; Brost R; Brune W
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28637762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of human cytomegalovirus microRNA expression during lytic and quiescent infection.
    Shen ZZ; Pan X; Miao LF; Ye HQ; Chavanas S; Davrinche C; McVoy M; Luo MH
    PLoS One; 2014; 9(2):e88531. PubMed ID: 24533100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of human cytomegalovirus UL138, a novel latency-associated determinant, by hcmv-miR-UL36.
    Huang Y; Qi Y; Ma Y; He R; Ji Y; Sun Z; Ruan Q
    J Biosci; 2013 Sep; 38(3):479-85. PubMed ID: 23938381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host microRNA regulation of human cytomegalovirus immediate early protein translation promotes viral latency.
    O'Connor CM; Vanicek J; Murphy EA
    J Virol; 2014 May; 88(10):5524-32. PubMed ID: 24599990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cytomegalovirus IE2 drives transcription initiation from a select subset of late infection viral promoters by host RNA polymerase II.
    Li M; Ball CB; Collins G; Hu Q; Luse DS; Price DH; Meier JL
    PLoS Pathog; 2020 Apr; 16(4):e1008402. PubMed ID: 32251483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA interference-mediated targeting of human cytomegalovirus immediate-early or early gene products inhibits viral replication with differential effects on cellular functions.
    Xiaofei E; Stadler BM; Debatis M; Wang S; Lu S; Kowalik TF
    J Virol; 2012 May; 86(10):5660-73. PubMed ID: 22438545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytomegalovirus microRNAs are carried by virions and dense bodies and are delivered to target cells.
    Mohammad AA; Costa H; Landázuri N; Lui WO; Hultenby K; Rahbar A; Yaiw KC; Söderberg-Nauclér C
    J Gen Virol; 2017 May; 98(5):1058-1072. PubMed ID: 28589873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Cytomegalovirus MicroRNAs miR-US5-1 and miR-UL112-3p Block Proinflammatory Cytokine Production in Response to NF-κB-Activating Factors through Direct Downregulation of IKKα and IKKβ.
    Hancock MH; Hook LM; Mitchell J; Nelson JA
    mBio; 2017 Mar; 8(2):. PubMed ID: 28270578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cytomegalovirus miR-UL112-1 promotes the down-regulation of viral immediate early-gene expression during latency to prevent T-cell recognition of latently infected cells.
    Lau B; Poole E; Van Damme E; Bunkens L; Sowash M; King H; Murphy E; Wills M; Van Loock M; Sinclair J
    J Gen Virol; 2016 Sep; 97(9):2387-2398. PubMed ID: 27411311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytomegalovirus uracil DNA glycosylase associates with ppUL44 and accelerates the accumulation of viral DNA.
    Prichard MN; Lawlor H; Duke GM; Mo C; Wang Z; Dixon M; Kemble G; Kern ER
    Virol J; 2005 Jul; 2():55. PubMed ID: 16022730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Cytomegalovirus miR-US33as-5p Targets IFNAR1 to Achieve Immune Evasion During Both Lytic and Latent Infection.
    Zhang Q; Song X; Ma P; Lv L; Zhang Y; Deng J; Zhang Y
    Front Immunol; 2021; 12():628364. PubMed ID: 33746965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cytomegalovirus-encoded MicroRNAs: A master regulator of latent infection.
    Abdalla AE; Mahjoob MO; Abosalif KOA; Ejaz H; Alameen AAM; Elsaman T
    Infect Genet Evol; 2020 Mar; 78():104119. PubMed ID: 31740397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Over-expression of human cytomegalovirus miR-US25-2-3p downregulates eIF4A1 and inhibits HCMV replication.
    Qi M; Qi Y; Ma Y; He R; Ji Y; Sun Z; Ruan Q
    FEBS Lett; 2013 Jul; 587(14):2266-71. PubMed ID: 23747307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of circulating hcmv-miR-UL112-3p in patients with glioblastoma, rheumatoid arthritis, diabetes mellitus and healthy controls.
    Mohammad AA; Rahbar A; Lui WO; Davoudi B; Catrina A; Stragliotto G; Mellbin L; Hamsten A; Rydén L; Yaiw KC; Söderberg-Nauclér C
    PLoS One; 2014; 9(12):e113740. PubMed ID: 25462570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.